JBT Marel (NYSE:JBTM – Get Free Report) released its earnings results on Monday. The company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.09, Zacks reports. The business had revenue of $936.00 million during the quarter. JBT Marel had a negative net margin of 1.33% and a positive return on equity of 7.68%. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.97 EPS. JBT Marel updated its FY 2026 guidance to 8.000-8.500 EPS.
JBT Marel Stock Performance
Shares of JBT Marel stock opened at $116.33 on Tuesday. JBT Marel has a one year low of $99.84 and a one year high of $170.19. The company has a market cap of $6.06 billion, a price-to-earnings ratio of -115.18, a PEG ratio of 1.22 and a beta of 0.92. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.58 and a current ratio of 0.98. The business’s 50 day moving average price is $135.85 and its 200 day moving average price is $143.84.
JBT Marel Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 23rd. Investors of record on Monday, March 9th were given a dividend of $0.10 per share. The ex-dividend date was Monday, March 9th. This represents a $0.40 dividend on an annualized basis and a yield of 0.3%. JBT Marel’s dividend payout ratio (DPR) is presently -39.60%.
Insider Buying and Selling
Institutional Trading of JBT Marel
A number of hedge funds and other institutional investors have recently made changes to their positions in JBTM. Alliancebernstein L.P. acquired a new stake in shares of JBT Marel during the 2nd quarter worth approximately $135,854,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in JBT Marel in the 2nd quarter valued at about $77,963,000. P2 Capital Partners LLC purchased a new stake in JBT Marel in the 2nd quarter valued at about $65,536,000. Adage Capital Partners GP L.L.C. purchased a new position in JBT Marel during the second quarter worth about $63,931,000. Finally, T. Rowe Price Investment Management Inc. boosted its stake in JBT Marel by 53.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,317,389 shares of the company’s stock worth $198,492,000 after buying an additional 458,980 shares during the period. Institutional investors and hedge funds own 98.92% of the company’s stock.
JBT Marel News Roundup
Here are the key news stories impacting JBT Marel this week:
- Positive Sentiment: Q1 beat on EPS and year?over?year revenue growth: JBTM reported $1.58 EPS (above the Zacks/Street consensus of $1.49) and revenue of $936M, up ~9.6% y/y — headlines framed this as an earnings beat that supported the rally. Zacks: Q1 Earnings and Revenues Surpass Estimates
- Positive Sentiment: Order momentum: Management said inbound orders topped $1 billion for the second consecutive quarter, signaling sustained demand across Prepared Food and Beverage solutions — a near?term growth signal for revenue cadence. BusinessWire: Q1 Results & Orders
- Neutral Sentiment: FY2026 guidance reiterated and centered near consensus: JBTM set EPS guidance of $8.00–$8.50 and revenue guidance of $4.0–$4.1B — broadly in line with sell?side expectations, so the guidance neither surprised strongly positive nor negative. BusinessWire: Guidance
- Neutral Sentiment: Revenue vs. some consensus estimates: One data source shows reported revenue ($936M) slightly below a $943.3M consensus — a modest miss that tempers the upside for investors focused on top?line beats. QuiverQuant: Revenue vs Consensus
- Negative Sentiment: Profitability and reported metric discrepancies: A third?party report highlights a sharp drop in operating profit, lower net income and a much lower diluted EPS figure in one presentation (and flags differing accounting/adjustments), which introduces confusion and a negative read for margin?sensitive investors. QuiverQuant: Profitability Concerns
- Negative Sentiment: Insider and institutional selling highlighted: Recent filings show multiple insider sales and notable institutional position reductions by some large holders — a potential headwind for sentiment if selling continues. QuiverQuant: Insider & Hedge Fund Activity
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. Zacks Research cut shares of JBT Marel from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of JBT Marel in a research note on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $174.50.
Check Out Our Latest Stock Report on JBT Marel
About JBT Marel
JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market.
Featured Articles
Receive News & Ratings for JBT Marel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBT Marel and related companies with MarketBeat.com's FREE daily email newsletter.
